Mechanism of Action The Triple G Pathway Retatrutide is a triple G agonist, acting on three key pathways: GLP-1 reduces appetite GIP supports metabolic signaling Glucagon receptor increases energy expenditure Triple G Pathway Retatrutide activates all three simultaneously The Role of Glucagon What makes retatrutide different from earlier therapies is glucagon activation
Slow dose escalation improves tolerance and minimizes the potential risks
The Study Gap Clinical trials focus on physical outcomesweight loss, blood sugar levels
Its important to focus on whole foods because these foods provide a package of nutrients like protein, dietary fibre, iron and calcium
At 48 weeks, the 12 mg dose achieved about 24 percent weight reduction
Dehydration, though often overlooked, is a critical aspect of post-weight-loss skin care